Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC44H74O11 |
InChIKeySNGCTKIKLPHLOE-UHFFFAOYSA-N |
CAS Registry207570-04-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Discovery | Japan | - |